CAVA Group Q3 revenue slightly misses estimates

By Reuters News


Overview

  • Mediterranean fast-casual chain's Q3 revenue grew, slightly missing analyst expectations

  • Net income for Q3 declined year-over-year, mainly due to higher depreciation and compensation


Outlook

  • CAVA raises 2026 same-restaurant sales growth outlook to 6.0%-7.0% from 4.5%-6.5%

  • Company now expects 76 to 78 net new restaurant openings in 2026, up from 75 to 77

  • CAVA sees 2026 adjusted EBITDA between $184 mln and $189 mln


Result Drivers

  • NEW RESTAURANT OPENINGS - Co said revenue growth was primarily driven by new restaurant openings exceeding performance expectations

  • MENU PRICING AND MIX - Same restaurant sales growth was attributed to higher menu prices, product mix, and slightly positive guest traffic

  • PRODUCE SAFETY CONCERNS - Same restaurant sales were negatively impacted by Cyclospora and concerns over fresh produce consumption


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Slight Miss*

$356.44 mln

$358.54 mln (22 Analysts)

Q3 EPS

$0.11

Q3 Net Income

$13.20 mln

Q3 Income from Operations

$15.001 mln

Q3 Pretax Profit

$18.68 mln

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 19 "strong buy" or "buy", 10 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the restaurants & bars peer group is "buy"

  • Wall Street's median 12-month price target for CAVA Group, Inc. is $82.00, about 36% above its November 3 closing price of $60.31

  • The stock recently traded at 85 times the next 12-month earnings vs. a P/E of 98 three months ago


Reuters Recommended Reads

  • Nov 3 - Yum Brands tops Q3 adjusted EPS estimates

  • Nov 4 - McDonald's Q3 revenue misses estimates on weaker US comparable sales

  • Nov 3 - Marzetti Q1 sales slightly miss, profit falls on cyclospora outbreak, higher costs


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.